Targeting Investigation and Treatment in Type 2 Myocardial Infarction

Targeting Investigation and Treatment in Type 2 Myocardial Infarction

Background: Type 2 myocardial infarction occurs in the absence of atherothrombosis, due to myocardial oxygen supply or demand imbalance, often during another acute illness. It is common and associated with poor clinical outcomes. No randomized controlled trials are available to guide investigation o...

Full description

Saved in:
Bibliographic Details
Main Authors: Caelan Taggart, MD, Amy Ferry, BSc, Stephanie Barker, BSc, Kelly Williams, BSc, Grace Souter, BSc, Anda Bularga, MD, Ryan Wereski, MD, Michael J. McDermott, MD, Michelle C. Williams, MD, PhD, Jasper Boeddinghaus, MD, Christopher White, BSc, Jagdeep S. Singh, MD, Keith Boath, BSc, Takeshi Fujisawa, PhD, Christopher Tuck, MSc, Anny Briola, MSc, Steff Lewis, PhD, Atul Anand, MD, PhD, Marc R. Dweck, MD, PhD, David E. Newby, MD, DSc, Rustam Al-Shahi Salman, MD, PhD, Nicholas L. Mills, MD, PhD, Andrew R. Chapman, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:JACC: Advances
Subjects:
coronary angiography
echocardiography
secondary prevention
type 2 myocardial infarction
universal definition
Online Access:http://www.sciencedirect.com/science/article/pii/S2772963X25001553
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2772963X25001553

Similar Items